medigraphic.com
Revista Latinoamericana de Microbiología

2006, Number 2

<< Back Next >>

Microbiología 2006; 48 (2)

Human and bovine tuberculosis in Latin America: From the studies about virulence to some tools for its control
The pathogen-potentially virulent components but with usefulness for diagnosis
El host-natural resistance to tuberculosis
Prevention of

López MLM, Díaz OF, Vallecillo MAJ, Esquivel SH, Gutiérrez PJA

Language: Spanish
References: 20
Page: 173-178
PDF size: 105.40 Kb.


ABSTRACT

Human and bovine tuberculosis (TB) are currently a serious health problem in Latin America. Although the causal agents were discovered more than one century ago, the control of these illnesses is still beyond our reach: human TB accounts for more than one hundred deaths each day in this region, whereas bovine TB represents a public health risk as well as a major economic problem. We herein analyze the situation of human and bovine TB in Latin America, and present studies from our laboratories on bacterial virulence factors, intrinsic resistance features in the host, and the protective response induced in cattle through vaccination or immunization. Finally, the convenience for implementing and/or revising the use of currently available tools for TB control in the region is discussed.


REFERENCES

  1. Brewer, T. F. 2000. Preventing tuberculosis with Bacille Calmette-Guérin vaccine: a meta-analysis of the literature. Clin. Infect. Dis. 31: S64-S67.

  2. Brosch, R., S. V. Gordon, M. Marmiesse, P. Brodin, C. Buchrieser, K. Eiglmeier, T. Garnier, C. Gutierrez, G. Hewinson, K. Kremer, L. M. Parsons, A. S. Pym, S. Samper, D. van Soolingen & S. T. Cole. 2002. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc. Natl. Acad. Sci. USA 99: 3684-3689

  3. Buddle, B. M., J. M. Pollock, M. A. Skinner & D. N. Wedlock. 2003. Development of vaccines to control bovine tuberculosis in cattle and relationship to vaccine development for other intracellular pathogens. Int. J. Parasitol. 33: 555-566.

  4. Caffey, J.P. 1994. Status of bovine tuberculosis eradication programmes in Europe. Vet. Microbiol. 40:1-4.

  5. Cole, S. T., R. Brosch, J. Parkhill, T. et al. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393: 537-544.

  6. De Kantor, I. N., & V. Ritacco. 2006. An update on bovine tuberculosis programmes in Latin American and Caribbean countries. Vet. Microbiol. 112: 111-118.

  7. Global tuberculosis control – surveillance, planning, financing. WHO TB Report 2006, World Health Organization, Geneva. 2006.

  8. Gutiérrez-Pabello, J.A., Adams, L.G., 2003. Survival of Mycobacterium bovis in macrophages from cattle naturally resistant and susceptible to intracellular pathogens. Vet. Mex. 34:277-281.

  9. Gutiérrez-Pabello, J.A., D. N. McMurray, & L. G. Adams. 2002. Upregulation of thymosin beta-10 by Mycobacterium bovis infection of bovine macrophages is associated with apoptosis. Infect. Immun. 70 (4):2121-2127.

  10. Human tuberculosis caused by Mycobacterium bovis – New York City, 2001 – 2004. 2005. Mortality and Morbidity Weekly Report. 54: 605-608.

  11. Hutt, F.B. 1958. Genetic resistance to disease in domestic animals. Comstock Publishing Associates, Ithaca, New York, 198 pp.

  12. Kramnik, I. & V. Boyartchuk. 2002. Immunity to intracellular pathogens as a complex genetic trait. Curr. Opin. Microbiol. 5:111-117.

  13. Kremer, L. & G. S. Besra. 2005. A waxy tale, by Mycobacterium tuberculosis, pp. 287-305. In S. T. Cole, K. D. Eisenach, D. N. McMurray & W. R. Jacobs, Jr. (Eds). Tuberculosis and the tubercle bacillus, American Society for Microbiology, Washington D. C.

  14. López Marín, L. M., E. Segura, C. Hermida-Escobedo, A. Lemassu & M. C. Salinas-Carmona. 2003. 6,6´-dimycoloyl trehalose from a rapidly growing Mycobacterium: an alternative antigen for tuberculosis serodiagnosis. FEMS Immunol. Med. Microbiol. 36: 47-54.

  15. OIE (World Organization for Animal Health), 2004. Annual Animal Disease Status, Bovine Tuberculosis. Accessed May 3, 2006. Available from: http://www.oie.int.

  16. Pan, H., B. S. Yan, M. Rojas, Y. V. Shebzukhov, H. Zhou, L. Kobzik, D. E. Higgins, M. J. Daly, B. R. Bloom & I. Kramnik. 2005. Ipr1 gene mediates innate immunity to tuberculosis. Nature. 434: 767-772.

  17. Qureshi, T., J. W. Templeton, & L. G. Adams. 1995. Intracellular survival of Brucella abortus, Mycobacterium bovis BCG, Salmonella dublin and Salmonella typhimurium in macrophages from cattle genetically resistant to Brucella abortus. Vet. Immunol. Immunopathol. 50:55-66.

  18. Saavedra, R., E. Segura, E. P. Tenorio & L. M. López Marín. 2006. Mycobacterial trehalose-containing glycolipid with immunomodulatory activity on human CD4+ and CD8+ T cells. Microbes Infect. 8: 533-540.

  19. Tala, E. O. & M. M. Tala-Heikkila. 1994. Pros and cons of BCG vaccination in countries with low incidence of tuberculosis. Infect. Control Hosp. Epidemiol. 15: 497-499.

  20. Thoen, C., P. LoBue & I. De Kantor. 2006. The important of Mycobacterium bovis as a zoonosis. Vet. Microbiol. 112: 339-345.




2020     |     www.medigraphic.com